The company hopes to accrue around 5,000 patients over the next few years, creating a broad dataset coupling outcomes with comprehensive DNA, RNA, and protein analyses.
In Science this week: epigenetic memory of environmental changes in roundworms, and more.
The firm is in the process of commercializing an open, optimizable, high-throughput library preparation instrument for single-cell transcriptome profiling.
These cell subtypes could help researchers gain a clearer understanding of cell mechanics and find better targets for potential therapies.
Incorporating splicing and other clues from muscle transcripts, researchers reached diagnoses in cases that were inconclusive after sequencing alone.
In PLOS this week: selective constraint within aspen tree buds, bird phylogenetic diversity varies by latitude, and more.
The lab-developed test will use Thermo Fisher Scientific's Ion sequencing platform and will be applicable to most childhood cancers.
In Nucleic Acids Research this week: model to determine methylation effects of noncoding variants, Neisseria meningitides transcriptomics, and more.
The Harvard spinout is commercializing inDrop single-cell sequencing technology developed by Allon Klein.
Cephalopods with complex hunting, behavioral, and social behavior seem to adjust post-transcriptional processes to adapt to changing environments.
Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.
Bill Gates tells the Telegraph that bioterrorism is a serious risk.
The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.
CBS News reports that the White House Science Fair is to continue under President Donald Trump.